PortfoliosLab logoPortfoliosLab logo
MIDU vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MIDU vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Mid Cap Bull 3X Shares (MIDU) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MIDU achieves a 41.54% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, MIDU has underperformed CURE with an annualized return of 12.76%, while CURE has yielded a comparatively higher 13.49% annualized return.


MIDU

1D
1.98%
1M
10.51%
YTD
41.54%
6M
35.51%
1Y
66.94%
3Y*
23.88%
5Y*
2.68%
10Y*
12.76%

CURE

1D
-0.55%
1M
13.53%
YTD
-7.96%
6M
-6.00%
1Y
26.46%
3Y*
3.05%
5Y*
1.51%
10Y*
13.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MIDU vs. CURE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MIDU
Direxion Daily Mid Cap Bull 3X Shares
41.54%-2.75%20.32%27.79%-49.27%72.89%-18.31%77.38%-39.21%46.86%
CURE
Direxion Daily Healthcare Bull 3x Shares
-7.96%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between MIDU and CURE is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.41

Correlation (3Y)
Calculated over the trailing 3-year period

0.48

Correlation (5Y)
Calculated over the trailing 5-year period

0.54

Correlation (10Y)
Calculated over the trailing 10-year period

0.57

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2011

0.62

Over the past year, the correlation between MIDU and CURE has dropped to 0.41 - well below their long-term average of 0.62, suggesting their price drivers have been diverging.

MIDU vs. CURE - Sectors Allocation Comparison


Sectors
MIDU
CURE

Industrials

25.0%

-

Technology

15.7%

-

Financial Services

14.4%

-

Consumer Cyclical

10.7%

-

Healthcare

8.6%
100.0%

Real Estate

7.5%

-

Energy

5.5%

-

Basic Materials

4.8%

-

Consumer Defensive

3.8%

-

Utilities

3.1%

-

Communication Services

1.0%

-

Industrials

MIDU
25.0%
CURE

-

Technology

MIDU
15.7%
CURE

-

Financial Services

MIDU
14.4%
CURE

-

Consumer Cyclical

MIDU
10.7%
CURE

-

Healthcare

MIDU
8.6%
CURE
100.0%

Real Estate

MIDU
7.5%
CURE

-

Energy

MIDU
5.5%
CURE

-

Basic Materials

MIDU
4.8%
CURE

-

Consumer Defensive

MIDU
3.8%
CURE

-

Utilities

MIDU
3.1%
CURE

-

Communication Services

MIDU
1.0%
CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MIDU vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MIDU
MIDU Risk / Return Rank: 5050
Overall Rank
MIDU Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
MIDU Sortino Ratio Rank: 4646
Sortino Ratio Rank
MIDU Omega Ratio Rank: 4242
Omega Ratio Rank
MIDU Calmar Ratio Rank: 5959
Calmar Ratio Rank
MIDU Martin Ratio Rank: 5656
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 2121
Overall Rank
CURE Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2424
Sortino Ratio Rank
CURE Omega Ratio Rank: 2222
Omega Ratio Rank
CURE Calmar Ratio Rank: 2222
Calmar Ratio Rank
CURE Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MIDU vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Mid Cap Bull 3X Shares (MIDU) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MIDUCUREDifference
Sharpe ratioReturn per unit of total volatility

+0.82

Sortino ratioReturn per unit of downside risk

+0.85

Omega ratioGain probability vs. loss probability

1.24

1.13

+0.11

Calmar ratioReturn relative to maximum drawdown

2.61

0.85

+1.75

Martin ratioReturn relative to average drawdown

8.65

1.94

+6.71

MIDU vs. CURE - Sharpe Ratio Comparison

The current MIDU Sharpe Ratio is 1.42, which is higher than the CURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of MIDU and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MIDU vs. CURE - Drawdown Comparison

The maximum MIDU drawdown since its inception was -86.26%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for MIDU and CURE.


Loading charts...

Drawdown Indicators


MIDUCUREDifference

Max Drawdown

Largest peak-to-trough decline

-86.26%

-69.19%

-17.07%

Max Drawdown (1Y)

Largest decline over 1 year

-25.80%

-31.10%

+5.30%

Max Drawdown (3Y)

Largest decline over 3 years

-60.41%

-51.93%

-8.48%

Max Drawdown (5Y)

Largest decline over 5 years

-64.14%

-52.23%

-11.91%

Max Drawdown (10Y)

Largest decline over 10 years

-86.26%

-69.19%

-17.07%

Current Drawdown

Current decline from peak

-1.48%

-26.94%

+25.46%

Average Drawdown

Average peak-to-trough decline

-22.41%

-18.16%

-4.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.77%

13.71%

-5.94%

Volatility

MIDU vs. CURE - Volatility Comparison

Direxion Daily Mid Cap Bull 3X Shares (MIDU) has a higher volatility of 15.07% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 14.30%. This indicates that MIDU's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MIDUCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.07%

14.30%

+0.77%

Volatility (6M)

Calculated over the trailing 6-month period

34.90%

30.87%

+4.03%

Volatility (1Y)

Calculated over the trailing 1-year period

47.43%

44.32%

+3.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.59%

43.84%

+15.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

63.65%

49.59%

+14.06%

MIDU vs. CURE - Expense Ratio Comparison

MIDU has a 1.06% expense ratio, which is lower than CURE's 1.08% expense ratio.


Dividends

MIDU vs. CURE - Dividend Comparison

MIDU's dividend yield for the trailing twelve months is around 0.63%, less than CURE's 1.16% yield.


PositionTTM2025202420232022202120202019201820172016
CURE
Direxion Daily Healthcare Bull 3x Shares
1.16%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%
MIDU
Direxion Daily Mid Cap Bull 3X Shares
0.63%1.04%1.10%1.43%0.11%0.00%0.06%0.71%0.70%2.67%1.89%

Frequently Asked Questions


MIDU and CURE have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MIDU has higher volatility (15.07%) compared to CURE (14.30%). In terms of maximum drawdown, MIDU dropped -86.26% vs CURE's -69.19%.

On 10-year performance, CURE leads with 13.49% vs 12.76% for MIDU. On fees, MIDU is cheaper at 1.06% per year. On volatility, CURE has been the lower-risk option at 14.30%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 13.49% return vs 12.76%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

MIDU is cheaper with a 1.06% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.16%, compared with 0.63% for MIDU.

MIDU tracks S&P MidCap 400 Index (300%), while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 1.06% for MIDU and 1.08% for CURE.

MIDU currently has the higher Sharpe Ratio (1.42 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MIDU and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer